Not applicableStudy completedNCT04856540What this trial is testingAdult Outcomes of Children With CAPSWho this might be right forCryopyrin Associated Periodic Syndrome University Hospital, Lille 54
Large-scale testing (Phase 3)Ended earlyNCT00770601What this trial is testingCanakinumab to Treat Neonatal-Onset Multisystem Inflammatory DiseaseWho this might be right forNOMIDCINCA Syndrome Novartis Pharmaceuticals 7
Not applicableNot Yet RecruitingNCT06544018What this trial is testingCircadian Rhythm Deregulation in Patients With CAPSWho this might be right forCryopyrin Associated Periodic SyndromeFamilial Cold UrticariaMuckle-Wells Syndrome+1 more Hospices Civils de Lyon 30
Large-scale testing (Phase 3)Study completedNCT00991146What this trial is testingEfficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension PhaseWho this might be right forCryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more Novartis Pharmaceuticals 19
Large-scale testing (Phase 3)Study completedNCT01302860What this trial is testingEfficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory DiseaseWho this might be right forCryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more Novartis Pharmaceuticals 17
Early research (Phase 1)Looking for participantsNCT06974877What this trial is testingRepeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid LoadWho this might be right forCryopyrin-Associated Periodic SyndromesAmyloidosis National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT00094900What this trial is testingInterleukin-1 Trap to Treat Autoinflammatory DiseasesWho this might be right forInflammationFamilial Mediterranean FeverStill's Disease, Adult-Onset National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 11
Not applicableStudy completedNCT01213641What this trial is testingClinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) PatientsWho this might be right forCryopyrin-associated Periodic Syndromes (CAPS)Familial Cold Autoinflam Syn (FCAS)Muckle-wells Syn (MWS)+1 more Novartis Pharmaceuticals 288
Testing effectiveness (Phase 2)Ended earlyNCT02853084What this trial is testingHL2351 CAPS Phase II StudyWho this might be right forCryopyrin-Associated Periodic Syndromes (CAPS) Handok Inc. 8
Not applicableLooking for participantsNCT02974595What this trial is testingNatural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)Who this might be right forNOMIDDIRANLRC4-MAS+2 more National Institute of Allergy and Infectious Diseases (NIAID) 3,200
Testing effectiveness (Phase 2)Ended earlyNCT00069329What this trial is testingAnakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory DiseaseWho this might be right forNervous System MalformationsArthropathy, NeurogenicUrticaria+1 more National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 43
Large-scale testing (Phase 3)Study completedNCT01576367What this trial is testingEfficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory DiseaseWho this might be right forCryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more Novartis Pharmaceuticals 17
Large-scale testing (Phase 3)Study completedNCT01105507What this trial is testingThe Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in CanadaWho this might be right forCryopyrin Associated Periodic Syndrome Novartis Pharmaceuticals 4
Large-scale testing (Phase 3)Study completedNCT00685373What this trial is testingEfficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory DiseaseWho this might be right forCryopyrin-Associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle Wells Syndrome+1 more Novartis 166